FDA pushes "consumer-friendly" presentation of quantitative data in DTC promotions

On Tuesday, the Food and Drug Administration (FDA or the agency) published a draft guidance document, "Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements," which offers recommendations on how companies can best present quantitative efficacy and risk information in direct-to-consumer (DTC) promotional materials.

Also on Tuesday, FDA issued three notices of agency information collection activities, highlighting its focus on promoting drug information transparency between the pharmaceutical industry and the consumer.

Read More: FDA pushes "consumer-friendly" presentation of quantitative data in DTC promotions


Download PDF Share Back To Listing
Loading data